Where does the chart mention her father's heart attack?

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Answered on 16 September 2026

In two places. The intake interview of 20 September 2023 records under family history: “Father: myocardial infarction at 58, stent, alive. Mother: type 2 diabetes, hypertension.” Intake 20.09.2023 The draft of today's ambient note records that she raised the topic herself: “worried since my father's heart attack, he was 58.” Ambient note 16.09.2026

The May check-up documentation does not repeat the family history, and the SCORE2 documented there was calculated without it; SCORE2 does not include family history, which is why the guideline treats a premature family history as a risk modifier on top of the score. A myocardial infarction in a first-degree male relative before 55 counts as premature; at 58 it is borderline and still worth weighing. Check-up 12.05.2026 Eur Heart J + 1

From the patient record3 of 14 documents

Intake interview, history and family history, 20 September 2023Anamnesis
Ambient note of today's consultation (draft, unsigned), 16 September 2026Ambient note
Check-up (Gesundheitsuntersuchung) documentation, SCORE2, 12 May 2026Check-up

1.SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.European Heart Journal. 2021;42:2439-2454. SCORE2 working group and ESC Cardiovascular risk collaboration.Trial
2.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.European Heart Journal. 2021;42:3227-3337. Visseren FLJ, Mach F, Smulders YM, et al.Guideline
SummaryRisk estimation with SCORE2 (40 to 69 years) and SCORE2-OP; risk modifiers include a family history of premature cardiovascular disease, lipoprotein(a), coronary artery calcium and psychosocial stress. In apparently healthy people at low-to-moderate risk, lipid-lowering treatment should be considered when LDL cholesterol stays at or above 2.6 mmol/l (100 mg/dl) after lifestyle intervention; a stepwise approach with treatment targets by risk category.
Source
Issuing body: European Society of Cardiology
Published: September 2021
Grading system: ESC classes of recommendation I–III, levels of evidence A–C
Scope
Target population: Apparently healthy people and patients with established disease
Scope: Risk assessment, lifestyle, lipids, blood pressure, diabetes

What would you like to ask next?

1Given her history and today's findings, what should I consider next?2Which findings are still open?3Which preventive care is due for her?

This is a sample workspace. Click one of the questions. To ask your own questions, request access.

Anna Keller, 47Mosaic